SEARCH

Search Details
Last Updated :2026/06/12



Medical Informatics Department
Assistant Professor

Research activity information

■ Paper
  • Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry
    Hidenori Sakai; Koshiro Sonomoto; Shingo Nakayamada; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Hiroaki Tanaka; Satoshi Kubo; Ippei Miyagawa; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Ryuichiro Kanda; Yoshiya Tanaka
    RMD Open, Jan. 2026
  • Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry
    Koshiro Sonomoto; Shingo Nakayamada; Hidenori Sakai; Masanobu Ueno; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Makoto Okawara; Akinori Nakata; Yoshiya Tanaka
    RMD Open, Jan. 2026
  • Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry
    Hidenori Sakai; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Kentaro Hanami; Shunsuke Fukuyo; Ayako Yamaguchi; Ippei Miyagawa; Masanobu Ueno; Hiroaki Tanaka; Yasuyuki Todoroki; Naoaki Ohkubo; Masashi Funada; Satsuki Matsunaga; Yoshiya Tanaka
    Rheumatology, Apr. 2025
  • A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry
    Koshiro Sonomoto; Yoshihisa Fujino; Hiroaki Tanaka; Atsushi Nagayasu; Shingo Nakayamada; Yoshiya Tanaka
    Rheumatology and Therapy, Jun. 2024
  • Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping
    Hiroaki Tanaka; Yukinori Okada; Shingo Nakayamada; Yusuke Miyazaki; Kyuto Sonehara; Shinichi Namba; Suguru Honda; Yuya Shirai; Kenichi Yamamoto; Satoshi Kubo; Katsunori Ikari; Masayoshi Harigai; Koshiro Sonomoto; Yoshiya Tanaka
    Annals of the Rheumatic Diseases, Jan. 2024
  • A Cross-Trait Genetic Correlation Study Identified Eight Diseases and Traits Associated with Psoriasis
    Kotaro Ogawa; Lam C. Tsoi; Hiroaki Tanaka; Masahiro Kanai; Philip E. Stuart; Rajan P. Nair; Yoshiya Tanaka; Hideki Mochizuki; James T. Elder; Yukinori Okada
    Journal of Investigative Dermatology, Sep. 2023
  • MCTD・強皮症 膠原病性肺高血圧症の予後予測因子の検討
    田中 宏明, 久保 智史, 中野 和久, 中山田 真吾, 平田 信太郎, 福與 俊介, 宮川 一平, 齋藤 和義, 山岡 邦宏, 田中 良哉
    日本リウマチ学会総会・学術集会プログラム・抄録集, Mar. 2015, Null, Null
  • 地域における骨粗鬆症性骨折減少への取り組み STOP-Fx study
    山中 芳亮, 栗之丸 直朗, 藤井 裕士, 田中 秀敏, 池田 聡, 田中 宏明, 河野 公昭, 熊谷 達仁, 西田 智, 畠山 英嗣, 弓指 恵一, 花石 源太郎, 岡田 祥明, 目貫 邦隆, 善家 雄吉, 酒井 昭典
    日本骨粗鬆症学会雑誌, May 2018, Reviewed, Invited
  • Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases
    Yuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, Hachirou Konaka, Rika Nishikawa, Kyuto Sonehara, Shinichi Namba, Hiroaki Tanaka, Tatsuo Masuda, Moto Yaga, Shingo Satoh, Mayuko Izumi, Yumiko Mizuno, Tatsunori Jo, Yuichi Maeda, Takuro Nii, Eri Oguro-Igashira; Biobank Japan Project; Takayuki Morisaki, Yoichiro Kamatani, Shingo Nakayamada, Chikako Nishigori, Yoshiya Tanaka, Yoshito Takeda, Kazuhiko Yamamoto, Atsushi Kumanogoh, Yukinori Okada
    Annals of the rheumatic diseases, Jun. 2022, Reviewed, No invitation
  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis.
    Ishigaki Kazuyoshi, Sakaue Saori, Terao Chikashi, Luo Yang, Sonehara Kyuto, Yamaguchi Kensuke, Amariuta Tiffany, Too Chun Lai, Laufer Vincent A, Scott Ian C, Viatte Sebastien, Takahashi Meiko, Ohmura Koichiro, Murasawa Akira, Hashimoto Motomu, Ito Hiromu, Masri Basel K, Barton Anne, Orozco Gisela, Bowes John, Honda Suguru, Koido Masaru, Tomizuka Kohei, Kamatani Yoichiro, Tanaka Hiroaki, Tanaka Eiichi, Suzuki Akari, Maeda Yuichi, Yamamoto Kenichi, Miyawaki Satoru, Xie Gang, Zhang Jinyi, Amos Christopher I, Keystone Edward, Wolbink Gertjan, Cui Jing, Carroll Robert J, Lee Hye-Soon, Bang So-Young, Siminovitch Katherine A, de Vries Niek, Alfredsson Lars, Mariette Xavier, Huizinga Tom, Schneider Matthias, Kerick Martin, Matsuda Koichi, Matsuo Keitaro, Mimori Tsuneyo, Matsuda Fumihiko, Fujio Keishi, Tanaka Yoshiya, Kumanogoh Atsushi, Arayssi Thurayya, Kochi Yuta, Ikari Katsunori, Harigai Masayoshi, Yamamoto Kazuhiko, Padyukov Leonid, Klareskog Lars, Okada Yukinori, Raychaudhuri Soumya
    Nature genetics, Nov. 2022, Reviewed, No invitation
  • Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
    Satoh-Kanda Yurie, Nakayamada Shingo, Kubo Satoshi, Yamagata Kaoru, Nawata Aya, Tanaka Hiroaki, Kosaka Shunpei, Kanda Ryuichiro, Yu Shan, Fujita Yuya, Sonomoto Koshiro, Tanaka Yoshiya
    RMD open, Jun. 2024, Reviewed, No invitation
  • Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
    Sakai Hidenori, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Hanami Kentaro, Fukuyo Shunsuke, Yamaguchi Ayako, Miyagawa Ippei, Ueno Masanobu, Tanaka Hiroaki, Todoroki Yasuyuki, Ohkubo Naoaki, Funada Masashi, Matsunaga Satsuki, Tanaka Yoshiya
    Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation
  • Predictors of the effectiveness to first-line CTLA4-Ig in patients with rheumatoid arthritis: the FIRST registry.
    Kobayashi Hiroki, Miyazaki Yusuke, Nakayamada Shingo, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Inoue Yoshino, Todoroki Yasuyuki, Miyata Hiroko, Tanaka Hiroaki, Fujino Yoshihisa, Hirata Shintaro, Tanaka Yoshiya
    Rheumatology (Oxford, England), May 2025, Reviewed, No invitation
  • Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
    Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
    Rheumatology (Oxford, England), May 2025, Reviewed, No invitation
  • Reduced homovanillic acid, SDF-1α, and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
    Yuya Fujita, Shigeru Iwata, Shinsuke Hidese, Sayuri Ishiwata, Satoru Ide, Hiroaki Tanaka, Koshiro Sonomoto, Yusuke Miyazaki, Shingo Nakayamada, Atsuko Ikenouchi, Kotaro Hattori, Hiroshi Kunugi, Reiji Yoshimura, Yoshiya Tanaka
    Rheumatology (Oxford, England), Feb. 2023, Reviewed, No invitation
  • TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
    Shan Yu, Nakayamada Shingo, Nawata Aya, Yamagata Kaoru, Sonomoto Koshiro, Tanaka Hiroaki, Satoh-Kanda Yurie, Nguyen Mai-Phuong, Todoroki Yasuyuki, Nagayasu Atsushi, Ueno Masanobu, Kanda Ryuichiro, Fujita Yuya, Zhang Tong, Hao He, Zhou Jieqing, Ma Xiaoxue, Anan Junpei, Nguyen Anh Phuong, Tanaka Yoshiya
    Rheumatology (Oxford, England), 2023, Reviewed, No invitation
  • Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry.
    Koshiro Sonomoto, Hiroaki Tanaka, Tuan Manh Nguyen, Hiroko Yoshinari, Kazuhisa Nakano, Shingo Nakayamada, Yoshiya Tanaka
    Rheumatology (Oxford, England), May 2022, Reviewed, No invitation
  • A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.
    Sonomoto Koshiro, Fujino Yoshihisa, Tanaka Hiroaki, Nagayasu Atsushi, Nakayamada Shingo, Tanaka Yoshiya
    Rheumatology and therapy, Mar. 2024, Reviewed, No invitation
  • Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry.
    Sonomoto Koshiro, Nakayamada Shingo, Tanaka Hiroaki, Nagayasu Atsushi, Tanaka Yoshiya
    Rheumatology and therapy, Apr. 2025, Reviewed, No invitation
  • Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
    Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
    Rheumatology and therapy, Aug. 2025, Reviewed, No invitation
  • The accumulation of healthy lifestyle behaviors prevents the incidence of chronic kidney disease (CKD) in middle-aged and older males.
    Michishita Ryoma, Matsuda Takuro, Kawakami Shotaro, Kiyonaga Akira, Tanaka Hiroaki, Morito Natsumi, Higaki Yasuki
    Environmental health and preventive medicine, May 2016, Null, Null
  • Influence of a home-based exercise program on the urine pH in elderly female subjects: a secondary analysis of a randomized controlled trial.
    Nishida Yuichiro, Tanaka Keitaro, Hara Megumi, Hirao Noriko, Tanaka Hiroaki, Tobina Takuro, Ikeda Masaharu, Yamato Hiroshi, Ohta Masanori
    European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity, 2017, Null, Null
  • Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy.
    Ohkubo Naoaki, Nakayamada Shingo, Fukuyo Shunsuke, Miyazaki Yusuke, Inoue Yoshino, Tanaka Hiroaki, Todoroki Yasuyuki, Tanaka Yoshiya
    International journal of rheumatic diseases, Jun. 2025, Reviewed, No invitation
  • The Association Between Unhealthy Lifestyle Behaviors and the Prevalence of Chronic Kidney Disease (CKD) in Middle-Aged and Older Men.
    Michishita Ryoma, Matsuda Takuro, Kawakami Shotaro, Kiyonaga Akira, Tanaka Hiroaki, Morito Natsumi, Higaki Yasuki
    Journal of epidemiology, Jul. 2016, Null, Null